Eevia Health Oyj (NGM:EEVIA)
Sweden
· Delayed Price · Currency is SEK 0.1395
0.00 (0.00%)
At close: May 14, 2025
Eevia Health Oyj Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Revenue | 1.79 | 4.61 | 5.76 | 6.81 | 2.93 | Upgrade
|
| Revenue Growth (YoY) | -61.20% | -20.03% | -15.35% | 132.52% | 108.50% | Upgrade
|
| Cost of Revenue | 0.85 | 1.49 | 2.98 | 5.18 | 1.51 | Upgrade
|
| Gross Profit | 0.94 | 3.12 | 2.78 | 1.63 | 1.41 | Upgrade
|
| Selling, General & Admin | 1.01 | 1.55 | 2.83 | 2.86 | 1.45 | Upgrade
|
| Other Operating Expenses | 0.27 | 0.99 | 0.65 | 0.87 | 0.66 | Upgrade
|
| Operating Expenses | 2.24 | 3.78 | 4.25 | 4.22 | 2.34 | Upgrade
|
| Operating Income | -1.31 | -0.66 | -1.47 | -2.59 | -0.92 | Upgrade
|
| Interest Expense | -0.57 | -0.24 | -0.63 | -0.07 | -0.11 | Upgrade
|
| Interest & Investment Income | - | 0.01 | 0.06 | 0.03 | 0.01 | Upgrade
|
| EBT Excluding Unusual Items | -1.88 | -0.89 | -2.04 | -2.64 | -1.02 | Upgrade
|
| Asset Writedown | -0.11 | - | - | - | - | Upgrade
|
| Pretax Income | -2 | -0.89 | -2.04 | -2.64 | -1.02 | Upgrade
|
| Net Income | -2 | -0.89 | -2.04 | -2.64 | -1.02 | Upgrade
|
| Net Income to Common | -2 | -0.89 | -2.04 | -2.64 | -1.02 | Upgrade
|
| Shares Outstanding (Basic) | 67 | 36 | 30 | 16 | - | Upgrade
|
| Shares Outstanding (Diluted) | 67 | 36 | 30 | 16 | - | Upgrade
|
| Shares Change (YoY) | 87.76% | 17.68% | 90.00% | - | - | Upgrade
|
| EPS (Basic) | -0.03 | -0.02 | -0.07 | -0.16 | - | Upgrade
|
| EPS (Diluted) | -0.03 | -0.02 | -0.07 | -0.16 | - | Upgrade
|
| Free Cash Flow | -1.61 | 0.28 | -2.19 | -3.31 | - | Upgrade
|
| Free Cash Flow Per Share | -0.02 | 0.01 | -0.07 | -0.21 | - | Upgrade
|
| Gross Margin | 52.29% | 67.75% | 48.23% | 23.98% | 48.28% | Upgrade
|
| Operating Margin | -73.10% | -14.36% | -25.58% | -38.04% | -31.52% | Upgrade
|
| Profit Margin | -111.58% | -19.22% | -35.44% | -38.71% | -34.95% | Upgrade
|
| Free Cash Flow Margin | -90.16% | 6.06% | -37.95% | -48.59% | - | Upgrade
|
| EBITDA | -0.35 | -0.05 | -0.92 | -2.25 | -0.77 | Upgrade
|
| EBITDA Margin | -19.30% | -1.01% | -16.04% | -33.07% | -26.42% | Upgrade
|
| D&A For EBITDA | 0.96 | 0.62 | 0.55 | 0.34 | 0.15 | Upgrade
|
| EBIT | -1.31 | -0.66 | -1.47 | -2.59 | -0.92 | Upgrade
|
| EBIT Margin | -73.10% | -14.36% | -25.58% | -38.04% | -31.52% | Upgrade
|
| Revenue as Reported | 2.49 | - | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.